Literature DB >> 6628156

Factors XI and XII are low in subjects with liver disease.

I R Walker, R A Milner, M A Johnston, C A Rand, P B Neame, J Hirsh.   

Abstract

We prospectively measured levels of factors XI and XII in parallel with other coagulation factors in 39 unselected patients with liver disease and in 20 control subjects. Mean levels of factors XI and XII in subjects with liver disease were significantly reduced, being 58% and 61%, respectively, compared with 100% and 94% in controls. Reductions in levels of factors XI and XII were most pronounced in those subjects with low serum albumin. The partial thromboplastin time (APTT) reflected low levels of either factor XI or XII and was most prolonged when both were low, but cause and effect was not demonstrated. Low levels of these factors may explain previous reports of poor response of APTT to infusions of prothrombin complex concentrates. Finally, these low levels strongly suggest that factors XI and XII are produced in the liver.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628156     DOI: 10.1007/bf01311723

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Assay of plasma thromboplastin antecedent (PTA) with artificially depleted normal plasma.

Authors:  H I HOROWITZ; W P WILCOX; M M FUJIMOTO
Journal:  Blood       Date:  1963-07       Impact factor: 22.113

2.  The specific assay of Prower-Stuart factor and factor VII.

Authors:  K W DENSON
Journal:  Acta Haematol       Date:  1961-02       Impact factor: 2.195

3.  The significance of the Hageman-factor for the effect of wettable surface on thrombocytes.

Authors:  J JUERGENS
Journal:  Thromb Diath Haemorrh       Date:  1962-03-15

4.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

5.  Plasma thromboplastin antecedent levels in patients receiving coumarin anticoagulants and in patients with Laennec's cirrhosis.

Authors:  S I RAPAPORT
Journal:  Proc Soc Exp Biol Med       Date:  1961-10

6.  Generation of coagulation factors V, XI, and XII by the isolated rat liver.

Authors:  C A Owen; E J Bowie
Journal:  Haemostasis       Date:  1977

Review 7.  The biology and pathology of the initial stages of blood coagulation.

Authors:  O D Ratnoff
Journal:  Prog Hematol       Date:  1966

8.  Use of factor-VII-rich prothrombin complex concentrate in liver disease.

Authors:  G Green; I W Dymock; L Poller; J M Thomson
Journal:  Lancet       Date:  1975-06-14       Impact factor: 79.321

9.  Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates.

Authors:  P M Mannucci; F Franchi; N Dioguardi
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

10.  Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen.

Authors:  L Biland; F Duckert; S Prisender; D Nyman
Journal:  Thromb Haemost       Date:  1978-06-30       Impact factor: 5.249

View more
  2 in total

1.  Factor XI protein in human pancreas and kidney.

Authors:  Qiufang Cheng; Jeanelle Kantz; Greg Poffenberger; Alvin C Powers; David Gailani
Journal:  Thromb Haemost       Date:  2008-07       Impact factor: 5.249

Review 2.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.